Fasturtec indikation
WebFasturtec is injected slowly into a vein, which should take about 30 minutes. Your dose will be calculated according to your body weight. The recommended dose is 0.20 mg per kg of body weight per day in both children and adults. It will be given once a day, for up to 7 days. WebFeb 21, 2024 · Fasturtec is given immediately before or during the start of chemotherapy. The recommended dose is 0.2 mg per kilogram body weight in both children and adults, given as a daily infusion for up to seven days. The duration of treatment is adjusted …
Fasturtec indikation
Did you know?
WebFasturtec is injected slowly into a vein, which should take about 30 minutes. Your dose will be calculated according to your body weight. The recommended dose is 0.20 mg per kg … WebElitek® is also commercially available under the brand name of Fasturtec® outside the United States. Elitek is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome ...
WebVV-LBL-0310822_8757346_1_0.pdf WebIndications and dose For rasburicase Prophylaxis and treatment of acute hyperuricaemia, before and during initiation of chemotherapy, in patients with haematological malignancy and high tumour burden at risk of rapid lysis for rasburicase …
WebJun 7, 2024 · Fasturtec is a recombinant urate-oxidase enzyme produced by a genetically modified Saccharomyces cerevisiae strain. The cDNA coding for rasburicase was cloned … WebJun 7, 2024 · Fasturtec(obs) is a recombinant form of urate-oxidase enzyme used to treat hyperuricemia following chemotherapy for leukemias and non-Hodgkin's lymphoma. For …
WebMar 28, 2024 · Fasturtec is provided as a powder for concentrate for solution for infusion (powder for sterile concentrate) with a solvent. The powder is an entire or broken white to off white pellet. The solvent is a colourless and clear liquid. Pack of 3 vials of 1.5 mg rasburicase and 3 ampoules of 1 ml solvent. The powder is supplied in 2 ml or 3 ml clear ...
Web1 INDICATIONS AND USAGE . 2 DOSAGE AND ADMINISTRATION . 2.1 Dosage . 2.2 Reconstitution Procedure . 2.3 Further Dilution and Administration . 3 DOSAGE FORMS AND STRENGTHS . 4 CONTRAINDICATIONS . 5 WARNINGS AND PRECAUTIONS . 5.1 Anaphylaxis . 5.2 Hemolysis . 5.3 Methemoglobinemia . 5.4 Laboratory Sample Handling … bipartisan campaign finance reform of 2002WebINDICATIONS AND CLINICAL USE FASTURTEC (rasburicase) is indicated for the treatment and prophylaxis of hyperuricemia in pediatric and adult cancer patients. CONTRAINDICATIONS FASTURTEC (rasburicase) should not be administered to patients with a known history of anaphylactic reactions or known history of hypersensitivity … bipartisan campaign reform act of 2002 bcra :WebIndikationen. Fasturtec ist zugelassen zur Behandlung und Prophylaxe der akuten Hyperurikämie, um ein Nierenversagen bei Patienten mit hämatologischen Malignomen … bipartisan campaign reform act hard moneyWebSep 26, 2024 · Some dosage forms listed on this page may not apply to the brand name Fasturtec. Applies to rasburicase ... lymphoma, or solid tumor malignancies receiving … daley thompson athleticsWebFasturtec is a recombinan t urate-oxidase enzyme produced by genetically modified Saccharomyces cerevisiae strain. Rasburicase is a tetrameric protein with identical … daley the golferWebJun 7, 2024 · Fasturtec (obs) is a recombinant form of urate-oxidase enzyme used to treat hyperuricemia following chemotherapy for leukemias and non-Hodgkin's lymphoma. For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy) Fasturtec (obs) is also used to associated treatment for these conditions: Hyperuricemia. daley terryWebRasburicase (trade names Elitek in the US and Fasturtec in the EU) is a medication that helps to clear uric acid from the blood. It is a recombinant version of urate oxidase, an … bipartisan budget act of 2015 p.l. 114-74